Here are healthcare safety issues that have appeared in the news and medical journals throughout the last 60 days or so:
The American College of Chest Physicians issued new recommendations published in Chest indicating that oral anticoagulants including Apixaban, Edoxaban, Rivaroxaban, or Dabigatran are now the preferred agents for long-term anticoagulation in patients. The exceptions include patients who are pregnant, who have cancer or who have severe renal insufficiency.
In an article published in the Journal of Pediatric Orthopedics, the authors recommended an MRI to investigate the possibility of adjacent infections in pediatric patients suffering from septic arthritis. A threefold increase of an adjacent infection was present in patients with three or more of the following risk factors: age older than 4 years; symptoms longer than three days, C-reactive protein (CRP) greater than 13.8 mg/dL; platelets less than 314,000/microL; and absolute neutrophil count higher than 8600/microL.
No comments:
Post a Comment